Novartis reported $38.14B in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19322M 802M
Astrazeneca AZN:US 20.92B 1.73B
AstraZeneca AZN:LN 20.92B 1.73B
Biogen BIIB:US $ 9740.9M 1825M
Bristol Myers Squibb BMY:US $ 30186M 65M
Canopy Growth Corp WEED:CN C$ 1.59B 143.83M
Catalent CTLT:US $ 2916M 109M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Gilead Sciences GILD:US $ 13705M 1076M
Glaxosmithkline GSK:US $ 54188M 25200M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Horizon Pharma HZNP:US $ 3203.09M 255.36M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 290.12M 28.59M
Novartis NOVN:VX 38.14B 906M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Phibro Animal Health PAHC:US $ 566.23M 19.76M
Prestige Brands PBH:US $ 324.62M 31.35M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Valeant Pharmaceuticals VRX:CN $ 6972.76M 1136.76M
Zoetis ZTS:US $ 6651M 186M